Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
225.8 SEK | +0.36% | -4.80% | -15.53% |
Jun. 10 | Global markets live: ABB, Roche, Microsoft, Apple, Tesla... | |
Jun. 10 | BioArctic Reports US FDA's Acceptance of Biologics License Application for Leqembi IV Maintenance Dosing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.53% | 1.93B | |
+48.00% | 56.61B | |
-7.74% | 39.62B | |
+35.65% | 39.25B | |
-6.90% | 28.28B | |
+10.45% | 26.44B | |
-16.64% | 20.12B | |
+29.35% | 12.51B | |
+29.85% | 12.48B | |
-0.49% | 12.2B |
- Stock Market
- Equities
- BIOA B Stock
- News BioArctic AB
- Transcript : BioArctic AB, Q1 2023 Earnings Call, Apr 27, 2023